Patents Assigned to ISSAR Pharmaceuticals Ltd
  • Angiogenic active lytic peptides
    Patent number: 9487560
    Abstract: This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: November 8, 2016
    Assignee: ISSAR Pharmaceuticals Ltd
    Inventor: Jesse Michael Jaynes